The MarketReader Minute
💊QURE Surges on Positive Trial Data, Intellia Therapeutics Faces Legal Challenge | Biotech Sector Insights
uniQure NV saw a surge after positive trial data for Huntington's disease treatment. Additionally, government regulations and economic policies are seen as crucial factors affecting the sector's outlook.